Oaklins Smith & Williamson has advised the shareholders of QMS Medicosmetics GmbH, a leading premium skin care brand, on the sale of the company to BlueGem Capital Partners LLP.
This transaction reflects an increase in private equity and venture capital activity in the luxury end of the sector.
Read more about the transaction, market trends, deal drivers and M&A valuation aspects.
© 2018 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.